• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Nitazoxanide : A Broad Spectrum Antimicrobial.硝唑尼特：一种广谱抗菌剂。
Med J Armed Forces India. 2011 Jan;67(1):67-8. doi: 10.1016/S0377-1237(11)80020-1. Epub 2011 Jul 21.
2
Use of nitazoxanide for gastrointestinal tract infections: treatment of protozoan parasitic infection and beyond.硝唑尼特在胃肠道感染中的应用：原生动物寄生虫感染及其他感染的治疗
Curr Infect Dis Rep. 2006 Mar;8(2):91-5. doi: 10.1007/s11908-006-0003-y.
3
Nitazoxanide: a new broad spectrum antiparasitic agent.硝唑尼特：一种新型广谱抗寄生虫药。
Expert Rev Anti Infect Ther. 2004 Feb;2(1):43-9. doi: 10.1586/14787210.2.1.43.
4
Effect of nitazoxanide on morbidity and mortality in Zambian children with cryptosporidiosis: a randomised controlled trial.硝唑尼特对赞比亚隐孢子虫病患儿发病率和死亡率的影响：一项随机对照试验。
Lancet. 2002 Nov 2;360(9343):1375-80. doi: 10.1016/S0140-6736(02)11401-2.
5
Nitazoxanide for the treatment of infectious diarrhoea in the Northern Territory, Australia 2007-2012.硝唑尼特用于治疗澳大利亚北领地2007 - 2012年感染性腹泻的研究
Rural Remote Health. 2014;14(2):2759. Epub 2014 Jun 12.
6
Nitazoxanide: clinical studies of a broad-spectrum anti-infective agent.硝唑尼特：一种广谱抗感染药物的临床研究
Future Microbiol. 2007 Dec;2(6):583-90. doi: 10.2217/17460913.2.6.583.
7
In vitro effects of nitazoxanide on Echinococcus granulosus protoscoleces and metacestodes.硝唑尼特对细粒棘球绦虫原头节和中绦期幼虫的体外作用
J Antimicrob Chemother. 2004 Sep;54(3):609-16. doi: 10.1093/jac/dkh386. Epub 2004 Jul 28.
8
Characterization of Giardia lamblia WB C6 clones resistant to nitazoxanide and to metronidazole.对硝唑尼特和甲硝唑耐药的蓝氏贾第鞭毛虫WB C6克隆的特性分析
J Antimicrob Chemother. 2007 Aug;60(2):280-7. doi: 10.1093/jac/dkm205. Epub 2007 Jun 8.
9
Nitazoxanide, a new drug candidate for the treatment of Middle East respiratory syndrome coronavirus.硝唑尼特，一种用于治疗中东呼吸综合征冠状病毒的新型候选药物。
J Infect Public Health. 2016 May-Jun;9(3):227-30. doi: 10.1016/j.jiph.2016.04.001. Epub 2016 Apr 16.
10
The efficacy of thuricin CD, tigecycline, vancomycin, teicoplanin, rifampicin and nitazoxanide, independently and in paired combinations against Clostridium difficile biofilms and planktonic cells.硫链丝菌素CD、替加环素、万古霉素、替考拉宁、利福平和硝唑尼特单独以及成对组合对艰难梭菌生物膜和浮游细胞的疗效。
Gut Pathog. 2016 Jun 2;8:20. doi: 10.1186/s13099-016-0102-8. eCollection 2016.

引用本文的文献

1
Efficacy and safety of nitazoxanide and escitalopram as adjuvant therapies in patients with rheumatoid arthritis: a randomized controlled study.硝唑尼特和艾司西酞普兰作为类风湿性关节炎患者辅助治疗的疗效和安全性：一项随机对照研究。
Eur J Clin Pharmacol. 2025 Sep 9. doi: 10.1007/s00228-025-03911-w.
2
Repurposing nitazoxanide in type 2 diabetes mellitus: a randomized controlled trial.硝唑尼特在2型糖尿病中的新用途：一项随机对照试验。
Endocrine. 2025 Aug 15. doi: 10.1007/s12020-025-04387-5.
3
Pseudohypoxia-Stabilized HIF2α Transcriptionally Inhibits , a Druggable Target in MELAS.假性低氧稳定的HIF2α转录抑制，MELAS中的一个可成药靶点。
Cells. 2025 Jul 15;14(14):1078. doi: 10.3390/cells14141078.
4
Nitazoxanide and tizoxanide demonstrate high levels of activity against metronidazole-susceptible and metronidazole-resistant clinical isolates.硝唑尼特和替唑尼特对甲硝唑敏感及耐药的临床分离株均表现出高活性。
Microbiol Spectr. 2025 Jul;13(7):e0271724. doi: 10.1128/spectrum.02717-24. Epub 2025 May 22.
5
Repurposing Nitazoxanide for Potential Treatment of Rare Disease Lymphangioleiomyomatosis.将硝唑尼特重新用于潜在治疗罕见疾病淋巴管平滑肌瘤病。
Biomolecules. 2024 Sep 30;14(10):1236. doi: 10.3390/biom14101236.
6
Why Certain Repurposed Drugs Are Unlikely to Be Effective Antivirals to Treat SARS-CoV-2 Infections.为何某些重新利用的药物不太可能成为治疗新冠病毒感染的有效抗病毒药物。
Viruses. 2024 Apr 22;16(4):651. doi: 10.3390/v16040651.
7
The Gut-Wrenching Effects of Cryptosporidiosis and Giardiasis in Children.隐孢子虫病和贾第虫病对儿童的严重影响。
Microorganisms. 2023 Sep 15;11(9):2323. doi: 10.3390/microorganisms11092323.
8
Analysis of Nucleolus as Drug Target: A Review.核仁作为药物靶点的分析：综述
Pharmaceuticals (Basel). 2023 Aug 16;16(8):1168. doi: 10.3390/ph16081168.
9
A determination of pan-pathogen antimicrobials?泛病原体抗菌药物的测定？
Med Drug Discov. 2022 Jun;14:100120. doi: 10.1016/j.medidd.2022.100120. Epub 2022 Jan 24.
10
Nitazoxanide Exerts Immunomodulatory Effects on Peripheral Blood Mononuclear Cells from Type 2 Diabetes Patients.硝唑尼特对 2 型糖尿病患者外周血单个核细胞发挥免疫调节作用。
Biomolecules. 2021 Dec 2;11(12):1817. doi: 10.3390/biom11121817.

本文引用的文献

1
Thiazolides: a new class of antiviral drugs.噻唑酰胺类：一类新型抗病毒药物。
Expert Opin Drug Metab Toxicol. 2009 Jun;5(6):667-74. doi: 10.1517/17425250902988487.
2
Effect of nitazoxanide for treatment of severe rotavirus diarrhoea: randomised double-blind placebo-controlled trial.硝唑尼特治疗重度轮状病毒腹泻的效果：随机双盲安慰剂对照试验
Lancet. 2006 Jul 8;368(9530):124-9. doi: 10.1016/S0140-6736(06)68852-1.
3
Epidemiology and control of intestinal parasites with nitazoxanide in children in Mexico.墨西哥儿童使用硝唑尼特治疗肠道寄生虫的流行病学及控制情况
Am J Trop Med Hyg. 2003 Apr;68(4):384-5.
4
Nitazoxanide pharmacokinetics and tolerability in man during 7 days dosing with 0.5 g and 1 g b.i.d.硝唑尼特在人体中的药代动力学及耐受性：每日两次服用0.5克和1克，连续给药7天
Int J Clin Pharmacol Ther. 2002 May;40(5):221-7. doi: 10.5414/cpp40221.
5
Treatment of diarrhea caused by Cryptosporidium parvum: a prospective randomized, double-blind, placebo-controlled study of Nitazoxanide.硝唑尼特治疗微小隐孢子虫引起的腹泻：一项关于硝唑尼特的前瞻性随机双盲安慰剂对照研究。
J Infect Dis. 2001 Jul 1;184(1):103-6. doi: 10.1086/321008. Epub 2001 May 29.
6
Pharmacokinetics of nitazoxanide after single oral dose administration in 6 healthy volunteers.6名健康志愿者单次口服硝唑尼特后的药代动力学。
Int J Clin Pharmacol Ther. 1996 Aug;34(8):349-51.

Nitazoxanide : A Broad Spectrum Antimicrobial.

作者信息

Singh Nishith, Narayan S

机构信息

Associate Professor, Department of Pharmacology, AFMC, Pune-40.

Classified Specialist (Paediatrics), Military Hospital, Golconda, AP.

出版信息

Med J Armed Forces India. 2011 Jan;67(1):67-8. doi: 10.1016/S0377-1237(11)80020-1. Epub 2011 Jul 21.

DOI:10.1016/S0377-1237(11)80020-1
PMID:27365765
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4920633/
Abstract
摘要